4
Changes in Ownership
TransMedics Group, Inc. Filed Acc 0000899243-22-035449
Chief Financial Officer sold 10,000 shares at $56.72 ($567,200)
- Chief Financial Officer acquired 10,000 shares (option exercise)
From the SEC's structured data for this filing
Trades in this filing
Table I: Non-derivative
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Gordon Stephen Chief Financial Officer | 2022-11-07 | Option exercise | +728 | $2.21 | $1,609 | 6,442 | D: show line 1 in the form |
| Gordon Stephen Chief Financial Officer | 2022-11-07 | Option exercise | +9,272 | $16.14 | $149,650 | 15,714 | D: show line 2 in the form |
| Gordon Stephen Chief Financial Officer | 2022-11-07 | Sale | −10,000 | $56.72 | $567,200 | 5,714 | D: show line 3 in the form |
| Open-market sales · 10,000 sh · avg $56.72 · $567,200 | |||||||
Table II: Derivative
| Insider | Date | Transaction | Shares | Price | Value | Exercise | Expires | Underlying | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|
| Gordon Stephen Chief Financial Officer | 2022-11-07 | Option exercise · Stock Option (Right to Buy) | −728 | 0 | D: show line 4 in the form | |||||
| Gordon Stephen Chief Financial Officer | 2022-11-07 | Option exercise · Stock Option (Right to Buy) | −9,272 | 40,728 | D: show line 5 in the form |
Loading xslF345X03/doc4.xml…